HEADER HORMONE 09-JUL-09 3I81 TITLE CRYSTAL STRUCTURE OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R-WT) TITLE 2 COMPLEX WITH BMS-754807 [1-(4-((5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO) TITLE 3 PYRROLO[2,1-F][1,2,4]TRIAZIN-2-YL)-N-(6-FLUORO-3-PYRIDINYL)-2-METHYL- TITLE 4 L-PROLINAMIDE] COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PROTEIN KINASE DOMAIN, UNP RESIDUES 982-1286; COMPND 5 SYNONYM: INSULIN-LIKE GROWTH FACTOR I RECEPTOR, IGF-I RECEPTOR; COMPND 6 EC: 2.7.1.112; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IGF1R; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS HORMONE/GROWTH FACTOR, IGF-1R, KINASE DOMAIN, ATP-BINDING, DISEASE KEYWDS 2 MUTATION, DISULFIDE BOND, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, KEYWDS 3 PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, KEYWDS 4 TYROSINE-PROTEIN KINASE, HORMONE EXPDTA X-RAY DIFFRACTION AUTHOR J.S.SACK REVDAT 3 21-FEB-24 3I81 1 COMPND REMARK SEQADV HETNAM REVDAT 2 01-NOV-17 3I81 1 REMARK REVDAT 1 22-DEC-09 3I81 0 JRNL AUTH M.D.WITTMAN,J.M.CARBONI,Z.YANG,F.Y.LEE,M.ANTMAN,R.ATTAR, JRNL AUTH 2 P.BALIMANE,C.CHANG,C.CHEN,L.DISCENZA,D.FRENNESSON, JRNL AUTH 3 M.M.GOTTARDIS,A.GREER,W.HURLBURT,W.JOHNSON,D.R.LANGLEY,A.LI, JRNL AUTH 4 J.LI,P.LIU,H.MASTALERZ,A.MATHUR,K.MENARD,K.PATEL,J.SACK, JRNL AUTH 5 X.SANG,M.SAULNIER,D.SMITH,K.STEFANSKI,G.TRAINOR, JRNL AUTH 6 U.VELAPARTHI,G.ZHANG,K.ZIMMERMANN,D.M.VYAS JRNL TITL DISCOVERY OF A 2,4-DISUBSTITUTED JRNL TITL 2 PYRROLO[1,2-F][1,2,4]TRIAZINE INHIBITOR (BMS-754807) OF JRNL TITL 3 INSULIN-LIKE GROWTH FACTOR RECEPTOR (IGF-1R) KINASE IN JRNL TITL 4 CLINICAL DEVELOPMENT. JRNL REF J.MED.CHEM. V. 52 7360 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19778024 JRNL DOI 10.1021/JM900786R REMARK 2 REMARK 2 RESOLUTION. 2.08 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.08 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.47 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 17738 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.690 REMARK 3 FREE R VALUE TEST SET COUNT : 655 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.08 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.14 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2518 REMARK 3 BIN R VALUE (WORKING SET) : 0.2586 REMARK 3 BIN FREE R VALUE : 0.3733 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.93 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 103 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2324 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 225 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.30470 REMARK 3 B22 (A**2) : -1.08790 REMARK 3 B33 (A**2) : 0.78310 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 3.06700 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.301 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3I81 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JUL-09. REMARK 100 THE DEPOSITION ID IS D_1000054080. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JUN-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MICROMAX CONFOCAL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 92 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17757 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.080 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.08 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.15600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: BUSTER 2.9.1 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 53.68300 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 20.54850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 53.68300 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 20.54850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 950 REMARK 465 VAL A 951 REMARK 465 SER A 952 REMARK 465 ALA A 953 REMARK 465 ALA A 954 REMARK 465 MET A 1068 REMARK 465 LYS A 1138 REMARK 465 GLY A 1139 REMARK 465 GLY A 1140 REMARK 465 LYS A 1141 REMARK 465 GLY A 1142 REMARK 465 MET A 1257 REMARK 465 GLU A 1258 REMARK 465 ASN A 1259 REMARK 465 ASN A 1260 REMARK 465 PRO A 1261 REMARK 465 VAL A 1262 REMARK 465 LEU A 1263 REMARK 465 ALA A 1264 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 955 CG OD1 OD2 REMARK 470 VAL A 956 CB CG1 CG2 REMARK 470 VAL A 958 CG1 CG2 REMARK 470 GLU A 967 CG CD OE1 OE2 REMARK 470 SER A 979 OG REMARK 470 GLU A1007 CG CD OE1 OE2 REMARK 470 ARG A1012 CD NE CZ NH1 NH2 REMARK 470 GLU A1067 CG CD OE1 OE2 REMARK 470 GLU A1069 CG CD OE1 OE2 REMARK 470 ARG A1128 CG CD NE CZ NH1 NH2 REMARK 470 ASP A1129 CG OD1 OD2 REMARK 470 ILE A1130 CG1 CG2 CD1 REMARK 470 ARG A1137 CD NE CZ NH1 NH2 REMARK 470 GLU A1213 CG CD OE1 OE2 REMARK 470 GLU A1254 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 956 130.85 78.54 REMARK 500 ASP A 960 -159.30 -122.99 REMARK 500 SER A 972 -105.93 -120.50 REMARK 500 LYS A 993 -120.42 58.37 REMARK 500 ASN A1070 -35.83 65.63 REMARK 500 ARG A1104 -18.63 72.23 REMARK 500 ARG A1128 -134.80 61.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EBI A 201 DBREF 3I81 A 952 1256 UNP P08069 IGF1R_HUMAN 982 1286 SEQADV 3I81 MET A 950 UNP P08069 EXPRESSION TAG SEQADV 3I81 VAL A 951 UNP P08069 EXPRESSION TAG SEQADV 3I81 MET A 1257 UNP P08069 EXPRESSION TAG SEQADV 3I81 GLU A 1258 UNP P08069 EXPRESSION TAG SEQADV 3I81 ASN A 1259 UNP P08069 EXPRESSION TAG SEQADV 3I81 ASN A 1260 UNP P08069 EXPRESSION TAG SEQADV 3I81 PRO A 1261 UNP P08069 EXPRESSION TAG SEQADV 3I81 VAL A 1262 UNP P08069 EXPRESSION TAG SEQADV 3I81 LEU A 1263 UNP P08069 EXPRESSION TAG SEQADV 3I81 ALA A 1264 UNP P08069 EXPRESSION TAG SEQRES 1 A 315 MET VAL SER ALA ALA ASP VAL TYR VAL PRO ASP GLU TRP SEQRES 2 A 315 GLU VAL ALA ARG GLU LYS ILE THR MET SER ARG GLU LEU SEQRES 3 A 315 GLY GLN GLY SER PHE GLY MET VAL TYR GLU GLY VAL ALA SEQRES 4 A 315 LYS GLY VAL VAL LYS ASP GLU PRO GLU THR ARG VAL ALA SEQRES 5 A 315 ILE LYS THR VAL ASN GLU ALA ALA SER MET ARG GLU ARG SEQRES 6 A 315 ILE GLU PHE LEU ASN GLU ALA SER VAL MET LYS GLU PHE SEQRES 7 A 315 ASN CYS HIS HIS VAL VAL ARG LEU LEU GLY VAL VAL SER SEQRES 8 A 315 GLN GLY GLN PRO THR LEU VAL ILE MET GLU LEU MET THR SEQRES 9 A 315 ARG GLY ASP LEU LYS SER TYR LEU ARG SER LEU ARG PRO SEQRES 10 A 315 GLU MET GLU ASN ASN PRO VAL LEU ALA PRO PRO SER LEU SEQRES 11 A 315 SER LYS MET ILE GLN MET ALA GLY GLU ILE ALA ASP GLY SEQRES 12 A 315 MET ALA TYR LEU ASN ALA ASN LYS PHE VAL HIS ARG ASP SEQRES 13 A 315 LEU ALA ALA ARG ASN CYS MET VAL ALA GLU ASP PHE THR SEQRES 14 A 315 VAL LYS ILE GLY ASP PHE GLY MET THR ARG ASP ILE TYR SEQRES 15 A 315 GLU THR ASP TYR TYR ARG LYS GLY GLY LYS GLY LEU LEU SEQRES 16 A 315 PRO VAL ARG TRP MET SER PRO GLU SER LEU LYS ASP GLY SEQRES 17 A 315 VAL PHE THR THR TYR SER ASP VAL TRP SER PHE GLY VAL SEQRES 18 A 315 VAL LEU TRP GLU ILE ALA THR LEU ALA GLU GLN PRO TYR SEQRES 19 A 315 GLN GLY LEU SER ASN GLU GLN VAL LEU ARG PHE VAL MET SEQRES 20 A 315 GLU GLY GLY LEU LEU ASP LYS PRO ASP ASN CYS PRO ASP SEQRES 21 A 315 MET LEU PHE GLU LEU MET ARG MET CYS TRP GLN TYR ASN SEQRES 22 A 315 PRO LYS MET ARG PRO SER PHE LEU GLU ILE ILE SER SER SEQRES 23 A 315 ILE LYS GLU GLU MET GLU PRO GLY PHE ARG GLU VAL SER SEQRES 24 A 315 PHE TYR TYR SER GLU GLU ASN LYS MET GLU ASN ASN PRO SEQRES 25 A 315 VAL LEU ALA HET EBI A 201 34 HETNAM EBI 1-{4-[(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)AMINO]PYRROLO[2,1- HETNAM 2 EBI F][1,2,4]TRIAZIN-2-YL}-N-(6-FLUOROPYRIDIN-3-YL)-2- HETNAM 3 EBI METHYL-L-PROLI NAMIDE HETSYN EBI BMS-754807 FORMUL 2 EBI C23 H24 F N9 O FORMUL 3 HOH *225(H2 O) HELIX 1 1 ALA A 965 GLU A 967 5 3 HELIX 2 2 SER A 1010 SER A 1022 1 13 HELIX 3 3 VAL A 1023 PHE A 1027 5 5 HELIX 4 4 ASP A 1056 LEU A 1064 1 9 HELIX 5 5 SER A 1078 ASN A 1099 1 22 HELIX 6 6 ALA A 1107 ARG A 1109 5 3 HELIX 7 7 TYR A 1131 TYR A 1135 5 5 HELIX 8 8 PRO A 1145 MET A 1149 5 5 HELIX 9 9 SER A 1150 GLY A 1157 1 8 HELIX 10 10 THR A 1160 LEU A 1178 1 19 HELIX 11 11 SER A 1187 GLU A 1197 1 11 HELIX 12 12 PRO A 1208 TRP A 1219 1 12 HELIX 13 13 ASN A 1222 ARG A 1226 5 5 HELIX 14 14 SER A 1228 LYS A 1237 1 10 HELIX 15 15 GLU A 1238 MET A 1240 5 3 HELIX 16 16 GLU A 1241 PRO A 1242 5 2 HELIX 17 17 GLY A 1243 SER A 1248 1 6 SHEET 1 A 5 ILE A 969 GLN A 977 0 SHEET 2 A 5 MET A 982 ALA A 988 -1 O GLU A 985 N ARG A 973 SHEET 3 A 5 THR A 998 THR A1004 -1 O ILE A1002 N TYR A 984 SHEET 4 A 5 LEU A1046 GLU A1050 -1 O MET A1049 N ALA A1001 SHEET 5 A 5 LEU A1035 VAL A1039 -1 N VAL A1039 O LEU A1046 SHEET 1 B 2 CYS A1111 VAL A1113 0 SHEET 2 B 2 VAL A1119 ILE A1121 -1 O LYS A1120 N MET A1112 CISPEP 1 GLN A 1043 PRO A 1044 0 1.04 CISPEP 2 ARG A 1128 ASP A 1129 0 2.26 SITE 1 AC1 17 HOH A 367 LEU A 975 GLN A 977 VAL A 983 SITE 2 AC1 17 ALA A1001 MET A1049 GLU A1050 MET A1052 SITE 3 AC1 17 THR A1053 GLY A1055 ARG A1109 ASN A1110 SITE 4 AC1 17 MET A1112 GLY A1122 ASP A1123 MET A1126 SITE 5 AC1 17 ARG A1128 CRYST1 107.366 41.097 78.816 90.00 120.57 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009314 0.000000 0.005502 0.00000 SCALE2 0.000000 0.024333 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014736 0.00000